CNC
Centene Corp
ACTIONABLEMethodology gates passed
Position levels
Currenttoday
USD 70.27
Buy <=wait / entry
USD 52.67
Trim >=take some off
USD 68.00
Thesis breakA material state Medicaid contract loss in 2026 or 2027, or guidance indicating ...
-
Scenario-weighted conviction
| Probability | Score | Contribution | |
|---|---|---|---|
| Bull case | 26% | 100 / 100 | 26.0 |
| Base case | 49% | 62 / 100 | 30.4 |
| Bear case | 25% | 10 / 100 | 2.5 |
| Weighted conviction | 59 / 100 - OPPORTUNISTIC BUY | ||
Top risks
- Q2 FY26 earnings beat with adjusted diluted EPS of $2.51 vs estimate $1.08 and revenue of $53.58B
- 2026 adjusted diluted EPS guidance raised to greater than $3.00 following Q1 2026 results of $3.11 EPS
- Analyst consensus Strong Buy with Argus Research upgrade and price target of 80